TRCT
AONC

Tower Research Capital (TRC)’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Tower Research Capital (TRC)’s Portfolio AONC Stock Details AONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-307
Closed -$1.69K – 6123
2024
Q1 		$1.69K Buy
307
+304
+10,133% +$1.75K ﹤0.01% 5205
2023
Q4 		$18 Buy
+3
New +$19 ﹤0.01% 5824
2023
Q2 		– Sell
-100
Closed -$1K – 6458
2023
Q1 		$1K Sell
100
-227
-69% -$2.31K ﹤0.01% 5667
2022
Q4 		$3K Sell
327
-46
-12% -$457 ﹤0.01% 5271
2022
Q3 		$4K Sell
373
-508
-58% -$4.99K ﹤0.01% 5313
2022
Q2 		$9K Buy
881
+100
+13% +$978 ﹤0.01% 4612
2022
Q1 		$8K Buy
781
+729
+1,402% +$7.08K ﹤0.01% 4637
2021
Q4 		$1K Sell
52
-661
-93% -$6.43K ﹤0.01% 5929
2021
Q3 		$7K Buy
713
+613
+613% +$5.94K ﹤0.01% 4693
2021
Q2 		$1K Buy
+100
New +$979 ﹤0.01% 5285

Other funds holding AONC

DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tower Research Capital (TRC)'s AONC Position: Q2 2024 in Review

Tower Research Capital (TRC) sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q2 2024, closing a stake of 307 shares — an estimated $1.69K sold.

Tower Research Capital (TRC) first reported a position in AONC in Q2 2021 and held it in 10 quarters. The position peaked at $9K in Q2 2022. 2 funds tracked by Wall St. Rank hold AONC as of Q2 2024.

  • Tower Research Capital (TRC) reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 307 American Oncology Network, Inc. Class A Common Stock shares in Q2 2024, an estimated $1.69K.
  • Tower Research Capital (TRC) first reported a position in American Oncology Network, Inc. Class A Common Stock in Q2 2021 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s American Oncology Network, Inc. Class A Common Stock position peaked at $9K in Q2 2022.
  • 2 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q2 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.